Home › Steatotic Liver Disease › California › Fresno
Steatotic Liver Disease clinical trials in Fresno, CA
5 studies for Steatotic Liver Disease are looking for participants at sites in and around Fresno (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Fresno
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Fresno
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RecruitingPhase 3
- Fresno Clinical Research Center, Fresno
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RecruitingPhase 3
- GSK Investigational Site, Riverdale · 22 mi away
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
RecruitingPhase 2
- GSK Investigational Site, Fresno
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- San Antonio, TX17 studies
- Miami, FL16 studies
- New York City, NY16 studies
- San Diego, CA14 studies
- Houston, TX13 studies
- Austin, TX13 studies
- Richmond, VA12 studies
- Tucson, AZ10 studies
- Chandler, AZ10 studies
- Orlando, FL9 studies
- Dallas, TX9 studies
- St. Louis, MO9 studies
Other studies in Fresno
- Non-Small Cell Lung Cancer7 studies
- Lung Cancer7 studies
- Breast Cancer6 studies
- Respiratory Distress Syndrome6 studies
- Acute Myeloid Leukemia5 studies
- Migraine5 studies
- Prostate Cancer5 studies
- Ovarian Cancer4 studies
- Acute Lung Injury4 studies
- Cancer (all types)4 studies
- Burkitt Lymphoma4 studies
- Myelodysplastic Syndromes3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.